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Abstract
Background: Clinical guidelines advocate for the inclusion of young people experiencing depression as well as
their caregivers in making decisions about their treatment. Little is known, however, about the degree to which
these groups are involved, and whether they want to be. This study sought to explore the experiences and desires
of young people and their caregivers in relation to being involved in treatment decision making for depressive
disorders.
Methods: Semi-structured interviews were carried out with ten young people and five caregivers from one
primary care and one specialist mental health service about their experiences and beliefs about treatment decision
making. Interviews were audio taped, transcribed verbatim and analysed using thematic analysis.
Results: Experiences of involvement for clients varied and were influenced by clients themselves, clinicians and
service settings. For caregivers, experiences of involvement were more homogenous. Desire for involvement varied
across clients, and within clients over time; however, most clients wanted to be involved at least some of the time.
Both clients and caregivers identified barriers to involvement.
Conclusions: This study supports clinical guidelines that advocate for young people diagnosed with depressive
disorders to be involved in treatment decision making. In order to maximise engagement, involvement in
treatment decision making should be offered to all clients. Involvement should be negotiated explicitly and
repeatedly, as desire for involvement may change over time. Caregiver involvement should be negotiated on an
individual basis; however, all caregivers should be supported with information about mental disorders and
treatment options.
Background
Experiencing depression as a child or adolescent can have
a significant impact on the social, occupational, physical
and emotional functioning of the young person [1,2].
This is of concern given that by the age of 18 years one
in every five people will have experienced depression [3].
It is crucial to provide optimal treatment for this age
group in order to minimise the negative impact of
depression on their lives [4]. Despite this need, a large
proportion of those young people experiencing depres-
sion will not access treatment [5,6], and for those who
do, many will experience significant delays before acces-
sing services [7,8]. There are a number of factors that
may lead to a delay in treatment, including stigma [9],
negative attitudes to, and experiences of, treatment
[10,11], and availability of services [12]. Once in treat-
ment, engagement remains a considerable challenge [13].
In order to maximize the chances of successful engage-
ment, a collaborative approach to treatment decision
making has been proposed for mental health treatment
in general [14] and for young people experiencing
depression specifically [15]. Clinical guidelines for the
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advocate for the inclusion of young people in learning
about and making decisions regarding their treatment
(e.g. [16]). Active involvement in treatment decision
making may lead to increased satisfaction with services
and therefore improve engagement and clinical outcomes
[17,18].
Involvement in treatment decision making has been
discussed in several ways. At a broad level, involvement
can be seen to be passive (e.g. paternalistic model of care
provided by a clinician, whereby the clinician shares little
information with the client, and the clinician deliberates
and makes the final decision about treatment); shared
(e.g. the client and clinician share information with each
other, both deliberate about this information and choose
a treatment option together); or autonomous (e.g. the cli-
ent may obtain information from the clinician but then
deliberates on this information and makes a decision
themselves) [19].
It is important to consider what constitutes involve-
ment. In the above model, the conceptualization of invol-
vement focuses on information sharing and making
actual decisions. Entwistle and Watt (2006) [20] suggest a
broadening of what constitutes involvement to include
both 1) participation in activities related to decision mak-
ing (with or without other people) and 2) the way that
people think and feel about such activities and people.
They describe three existing domains of involvement
(communication between clients and clinicians about
decision making; efforts made by the client in relation to
decision making; and efforts made by the clinician in
relation to decision making), and propose that two
further areas should be considered in order to create a
more meaningful understanding of client involvement: 1)
the way in which clients view, and feel about, these first
three domains as well as their role in, and contribution
to, the decision-making process; and 2) consideration of
the feelings of both the client and clinician about their
relationship with each other.
It is also important to consider the ways in which clients
may wish to be involved in the decision making process.
Deber and colleagues (2007) [21] conceptualise two cate-
gories related to making decisions: 1) problem solving,
which refers to a scenario where there is only one possible
correct answer and is therefore not able to be influenced by
client preferences; and 2) decision making, which may be
based on problem solving, that can be influenced by client
preferences and involves some consideration of the poten-
tial pros and cons of different scenarios (e.g. treatment
options). For each of these categories, it is proposed that
clients can prefer to ‘keep’ the responsibility themselves,
‘share’ responsibility with a clinician, or ‘hand over’ respon-
sibility to a clinician. Combinations of these preferences
then fall under categories of preference for involvement in
decision making (e.g. passive, shared, autonomous).
Recently, a ‘shared’ model of client involvement in decision
making, called shared decision making, has received
increased interest in both research and clinical settings.
Shared decision making (SDM) facilitated by the use of
decision aids (DAs) has been well tested in areas such as
breast cancer treatment decision making [e.g. [22]] and
choosing whether or not to undertake screening for pros-
tate cancer [e.g. [23]]. The most common model of SDM
is that described by Charles and colleagues [24], which
involves three major steps: 1) two parties (e.g. doctor and
patient) provide each other with relevant information; 2)
these same two parties deliberate on the decision by dis-
cussing the treatment options and preference for each
option; and 3) a treatment option is selected that is con-
sistent with patient preferences and values. This model
was updated in 1999 [19] to further detail these stages of
decision making (e.g. that information exchange com-
prises flow, direction, type and amount of information),
to acknowledge that approaches taken to decision mak-
ing are not necessarily static and may indeed change over
time, to describe sub-categories of decision making
approaches that are hybrid versions of the broader pater-
nalistic, shared and autonomous categories, and to make
the SDM model more relevant to clinical, research and
educational purposes (e.g. helping clinicians to under-
stand the different variations of involvement). Edwards
and Elwyn (2006) [25] have highlighted the importance
of focusing on the process of decision making (e.g. pre-
sentation of treatment options, information sharing and
consideration of preferences for who should make the
decision) rather than on who makes the actual decision.
DAs are evidence-based tools that provide information
about the potential risks and benefits of treatment options
(or other health related choices such as screening tests)
and are designed to elicit patient preferences in relation to
these options. In doing so, they are also designed to facili-
tate the exchange of information and increase the amount
of information shared between the healthcare provider
and consumer. The establishment of the International
Patient Decision Aid Standards (IPDAS), means that the
quality of DAs can now be assessed [26].
Despite enthusiasm for the application of SDM for
mental disorders [e.g. [27,28]] a recent systematic review
concluded that only two randomized controlled trials
(RCTs) had been conducted investigating SDM for men-
tal disorders [29]. The first study was a cluster RCT that
tested an intervention that involved SDM training for
physicians and a DA for adult outpatients diagnosed with
depressive disorders [30]. The intervention significantly
increased patient involvement and satisfaction without
increasing the duration of consultations; however, the
SDM intervention had no impact on level of depression
severity. The second study was a single site RCT that
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diagnosed with schizophrenia [31,32]. The intervention
demonstrated that SDM was feasible for this population,
and significantly increased patients’ knowledge about
schizophrenia, uptake of psychoeducation, and feelings of
involvement in consultations, again, without increasing
consultation time. However, as with the first study, clini-
cal symptom severity did not improve.
Despite there only being two RCTs testing interven-
tions specific to SDM and the use of DAs, there have
been a number of efforts in recent years that have taken
a person-centered approach to interventions for depres-
sion and other mental disorders. Most collaborative care
models (CCMs) in the US, for example, have incorpo-
rated patient-centered decision making processes and
have been demonstrated to improve clinical outcomes
such as adherence to medication, depression severity,
quality of life and patient satisfaction [33]. CCMs have
largely been tested in adults; however, a small number of
studies have been reported in young people diagnosed
with depressive disorders [34-37]. Of the three studies
located, two involved client choice as part of the inter-
vention, and one did not, as described below.
A small pilot study was conducted testing a CCM
based on an intervention designed for older adults and
adapted for young people 12-18 years being seen in pri-
mary care [34]. The 6-month intervention included client
choice of treatment with input from caregivers, and was
found to be acceptable to young people, their caregivers
and physicians, and depression scores improved for the
majority of participants. Two RCTs have been conducted;
the first randomized participants to either 12 months of
treatment as usual (TAU; predominantly prescription of
SSRI medication alone) or TAU plus brief cognitive
behavioural therapy (CBT; five to nine sessions), ongoing
consultation with a therapist and primary care provider,
and follow up contact via phone for 12 months [35]. Par-
ticipants were not offered a choice in terms of medica-
tion or psychological therapy. A weak effect was found
for the CCM intervention, which may have been influ-
enced by the TAU condition being relatively effective,
the small sample sizes and the low adherence to selective
serotonin reuptake inhibitor (SSRI) medication in the
CCM intervention group. The second RCT, the Youth
Partners in Care study [36,37] designed an intervention
aimed to provide young people aged 13-21 years who
were being seen in primary care settings with improved
access to evidence-based treatments and compared this
to usual care. As part of the CCM intervention, partici-
pants were informed about, and involved in, making deci-
sions about treatment options. Similar to results of
studies with adults, the 6-month intervention signifi-
cantly improved depression severity, quality of life and
patient satisfaction. While there is an increased cost
associated with CCMs, they may in fact be a prudent
investment given their effectiveness in improving clinical
outcomes and the financial costs and losses seen with
untreated depression. The results from these studies offer
insight into the effects of CCMs, yet it is difficult to tease
apart the contribution of the patient-centered elements.
Therefore, the effects seen with CCMs compared to
SDM only interventions may be somewhat different.
Both SDM approaches and CCM approaches that afford
participants treatment choice, assume that clients have a
desire to be involved in making decisions about their own
treatment and care. A narrative review investigating
factors related to patient preference for involvement in
decision making concluded that this was influenced by
demographic variables, experiences of illness and medical
care, diagnosis/health status, type of decision, patient lit-
eracy about their condition, attitude towards involvement
and relationships with health providers [38]. Studies inves-
tigating preference for involvement in adults diagnosed
with mental disorders have found a consistent and strong
preference for involvement [39,40], and that it is feasible
to do so [e.g. [41]]. Despite a desire for involvement, stu-
dies measuring levels of SDM in consultations relating to
adults with mental disorders have consistently found low
levels of involvement [40-45] and the authors were unable
to find any studies that have measured SDM behaviours
within consultations with young people diagnosed with
mental disorders, nor preference for involvement in young
people with mental health disorders. The context for treat-
ment decision making for depression is likely to be differ-
ent than treatment decision making in other health areas
[46], and for young people even more so. Given this, there
is a need to consider factors related specifically to this
population.
Qualitative methods have been used to investigate spe-
cific aspects of depression care for different populations.
Adult participants enrolled in a CCM intervention study
were interviewed about their experience of collaborative
care, and these data were used to amend and improve
the model for future research projects [47]. Focus groups
have been used to investigate the attitudes and prefer-
ences of different ethnic groups in relation to treatment
for depression [48], as well as stigmatizing beliefs about
depression and help seeking for depression [49]. These
studies have highlighted the importance of stigma on
help seeking behaviours and adherence to treatment.
Experiences and beliefs about treatment for depression
have been explored in interviews with adults [46] and, of
specific relevance to this study, young people aged 14-19
years who were involved in either interviews or a focus
group [50]. Both the adult and adolescent samples
wanted more information about depression and the avail-
able treatment options, as well as support from their clin-
icians to make treatment decisions.
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clients seen in tertiary mental health settings, we felt that
a descriptive account of young peoples’ experiences and
beliefs about treatment decision making for depression
would be a useful starting point from which further work
into SDM and DAs for this population could build upon.
We also felt that obtaining accounts from caregivers was
imperative given the ages/developmental stages and the
likely involvement of caregivers in the decision making
processes. The aim of the current study therefore was to
investigate the experiences and beliefs of young people
who had been diagnosed with depressive disorders and
their caregivers. Specifically, of interest was the degree to
which young people and their caregivers were involved in
treatment decision making, and how involved they
wished to be. First and foremost, this study sought to
obtain rich descriptive data on the above topics in and of
themselves; however, a secondary purpose was to investi-
gate whether or not treatment decision making could be
improved at each service and to use the data to inform
the development of a decision support tool.
Methods
Research team and reflexivity
The interviews were conducted by MS a female PhD can-
didate with experience in conducting qualitative, semi-
structured and structured clinical research interviews with
young people diagnosed with mental disorders. A relation-
ship was established briefly with each interviewee by tele-
phone and again in person before the interview.
Study design
An overarching social constructionist perspective guided
this project [51,52], and the methodology employed was
thematic analysis [53]. The interview probes were designed
to ‘lead’ the interviewee as little as possible, and the dialo-
gue between the interviewer and interviewee was treated
as equally relevant to the data. Ethics approval was
obtained from the relevant local committee (Melbourne
Health Research and Ethics Committee; reference number
2008.19). Parental or guardian consent was obtained for
participants aged less than 18 years old.
Participant selection
A purposive sample was recruited, as we wanted to
obtain descriptions of experiences and beliefs from
young people and caregivers who had experienced and
preferred different involvement styles in relation to treat-
ment decision making for young people. The project was
presented to clinicians from each service at staff and clin-
ical review meetings, after which clinicians were asked to
provide information about the study to clients and care-
givers who met the inclusion criteria. Interviews were
conducted until a diverse range of experiences and views
had been covered, including experiences with school
based services, primary care services, and both public and
private specialist mental health services. Additionally,
interviews were conducted until rich descriptions of pas-
sive, shared and autonomous involvement, from a variety
of clients and caregivers, both in terms of experiences of
and desire for such involvement. Time was taken to
review interview data as recruitment proceeded in order
to ensure that the data collection ceased only once all
these domains had been covered. Ten clients and five
caregivers were recruited in all. Fewer caregivers were
recruited because their experiences and views were more
homogenous and saturation was achieved sooner.
Inclusion Criteria
￿ Young people aged 12-24 years old who had received
treatment for a major depressive disorder (MDD) whilst
aged between 12 and 18 years old; or
￿ Any caregiver of a young person aged 12-18 years
old, where the young person has been in receipt of
treatment for MDD.
￿ Sufficient language skills and intellectual capacity to
provide informed consent and participate and not cur-
rently experiencing a psychotic episode
Setting
Participants were recruited from two services between
October 2008 and May 2009: Orygen Youth Health (a
specialist youth mental health service for young people
aged 15-24 living in the north western metropolitan area
of Melbourne, Australia) and headspace Barwon (an
enhanced general practice service for young people aged
12-25 living in the satellite city of Geelong, 75 kms
south-west of Melbourne).
Data collection
The interview probes were based on a previously pub-
lished focus group schedule [54] and modified to meet
the aims of the project (see additional file 1: Interview
probes). Rather than following the probes verbatim,
interviewees were initially asked to describe their experi-
ences of treatment decision making and were then
afforded the opportunity to describe these experiences in
their own way. The interviewer was then free to ask for
clarification or to encourage participants to elaborate
further on their accounts. The probes were then used at
appropriate time points as the interviewees described
their experiences, or to facilitate discussion if the inter-
viewee was slow to generate discussion, and again at the
end of each interview to address any topics that had not
already been covered. Two additional probes were added
(as seen in additional file 1: Interview probes); ‘What dif-
ferent types of service experiences have you had?’ was
used as the first probe in order to encourage interviewees
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tutes true involvement for you?’ was added in order to
clarify the ways in which interviewees conceptualized
involvement. The interviews were audio recorded and
transcribed using an orthographic (verbatim) style, and
field notes were taken during each interview. Each inter-
view lasted between 13 and 110 minutes (mean = 43.6
minutes).
Data analysis
Analysis was undertaken in accordance with Braun and
Clarke’s description of thematic analysis [53]. The analysis
was theoretically driven in that main themes were decided
before the interviews were conducted (and the interview
probes were based on these themes, for example ‘experi-
ences of involvement in treatment decision making’), how-
ever the analysis was also inductive to an extent in that
new themes were also derived from the data. More specific
coding was done within each theme. Initial data coding
occurred during transcription, followed by a secondary
coding process conducted after all interviews had been
transcribed. Themes were then compared within and
across groups (clients and caregivers). Theme and coding
matrices were used to organize data items and sets and to
generate a thematic map. When analyzing accounts of
involvement, themes were informed by Charles et al’s [19]
description of decision making approaches and analytical
stages of decision making, as well as the distinction drawn
by Elwyn and Edwards [25] between the decision-making
process and who actually makes the final decision (both
described above). Once analyzed, the data were summar-
ized in a report sent to participants inviting feedback.
Results
The key findings are summarized in Table 1. A more
detailed description is given below.
Participants
Of the ten clients who participated, 5/10 (50%) were male,
8/10 (80%) had a self reported comorbid mental disorder
(anxiety disorders, borderline personality disorder, sub-
stance use disorder and/or Asperger’s disorder) and their
ages ranged between 15 and 24 years old (mean age 20.3
years). All caregivers were female, aged between 40 and 55
years old (mean age 47.2 years), and caring for their own
offspring (not necessarily the clients participating in this
study).
What currently occurs?
Client involvement
Experiences of involvement in the decision-making pro-
cess varied across clients, as well as across different ser-
vices and clinicians. Clients’ experiences of involvement
did not always match their preferred level of involvement.
Most clients wanted some form of collaborative involve-
ment, whereby they would be involved in the analytical
stages of decision making (as described by Charles and
colleagues [19]) along with their clinician. Yet it was
common for the same client to experience both colla-
borative and paternalistic models (e.g. where involvement
of clients was passive in that they were involved at a very
minimal level). For example, client 01 described very pas-
sive experiences of treatment decision making, where his
input and information sharing was minimal:
“the doctors used me to ascertain my medical his-
tory because I was the only one who could remem-
ber all of the drugs that I had been on, um, and that
w a sa sf a ra sm yi n v o l v e m e n tw e n ti nt h ep r o c e s s ,
and as for information... nuh”
Rather than feeling as if he was part of the decision-
making process, he reported that he “would be sitting in
the corner and they (clinician and caregiver) would be
talking about me”. Client 04, on the other hand, who was
comfortable with researching treatment options in his
own time, experienced a very collaborative approach with
his psychiatrist in regards to decision making about medi-
cation. Along with open discussions between them during
appointments, they also both took on tasks related to the
decision-making process:
“s h eg a v em eal i s to ft w oo rt h r e ed i f f e r e n tm e d i c a -
tions and said that these would probably be one of
these would probably be what you’d be on... and she
said go home and do some research on them if you
want and tell me what you would like to be on if you
do choose to go on medication”
Clients reported less involvement in decision making
when treated on an inpatient unit, in detoxification units
and forensic services. In these examples they described
not only having decisions made for them, but also a lack
of shared information exchange or deliberation [19]. One
example of this was provided by client 01 who described
his experiences at inpatient units as “horrible” and like
being in a “dictatorship":
“Sometimes you don’t even know where the decisions
are coming from... they just like get made and you
have to live with the consequences of those deci-
sions... it’s like, I’v eb e e ni nt h e r eb e f o r ea n dl i k eh a d
a nurse bring a cup of medication out to me... and I
wasn’t taking medication the day before when I came
in, all of a sudden there was this huge cup of medica-
tion in front of me. I hadn’t even seen a doctor”
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Clients Caregivers
Experiences: Client
involvement
￿ Varied according to client, clinician and service
￿ Didn’t always match preference
￿ Most clients experienced different types of involvement
￿ Less involved in certain settings (e.g. detoxification units,
inpatient units)
￿ Satisfaction with level of involvement varied
￿ Usually encouraged involvement of their offspring
￿ Did so to promote engagement in service and personal
development
Experiences:
Caregiver
involvement
￿ Many clients did not have caregivers involved
￿ Clients who did not have caregivers involved described
finding decision making challenging due to a lack of support
￿ Clients who did have caregivers involved described at least
one negative experience each where caregiver involvement
was detrimental to decision making
￿ Experiences relatively homogenous
￿ Felt involvement was usually limited to practical tasks
￿ At times felt removed from clinical encounters, including
treatment decision making
￿ Caregivers asked for information about their child but not
always given the information they wanted
￿ Satisfaction with level of involvement varied and was
influenced by characteristics of the young person and of the
caregiver themselves
￿ Many caregivers found confidentiality policies based on age
problematic
Experiences:
Clinician
involvement
￿ All clients wanted some clinician involvement
￿ Some clients wanted only specific clinicians involved (e.g.
case manager but not doctor)
￿ All but one client wanted clinician involvement to be of a
collaborative nature
￿ Most clients wanted to weigh up the potential risks and
benefits of treatment options with clinicians
￿ Most caregivers wanted to trust clinicians as experts
￿ Most caregivers wanted to be trusted as those who knew
the most about their children
￿ Caregivers reported either themselves or the clinician
making the final decision
￿ Trust in clinicians was dependant on perceived quality of
care
Experiences:
Information
￿ Provision of information varied across clients, clinicians,
services, and also within clients across time
￿ Information received was lacking or poor
￿ Many clients sought information elsewhere
￿ Some clients felt reluctant or unable to ask for more
information
￿ Information valued as important for decision-making
￿ Clients wanted honest information about treatment options
and likely outcomes to facilitate realistic expectations
￿ Provision of information was poor
￿ Lack of information compounded feelings of exclusion and
confusion
￿ Some caregivers received information via their child
￿ Some caregivers sought information elsewhere
Beliefs: Desire for
involvement
￿ Desire for involvement varied both within and across clients
￿ Most clients wanted a collaborative style
￿ Trust, age, severity of symptoms and levels of support
influenced preference for involvement
￿ Clients distinguished between decision making process and
making the final decision
￿ All caregivers wanted some involvement
￿ Degree of preferred involvement varied, including
preference for who makes the final decision
Beliefs: Importance
of involvement
￿ Client involvement important for engagement process,
adherence to treatment, safety, autonomy and
empowerment
￿ Consideration of personal characteristics, values and
preferences was important to clients
￿ Having the final say was perceived as a basic right
￿ Caregiver involvement important because of knowledge
about offspring and continuity of care compared with
limited time with clinicians
￿ Client involvement important but extent of preference for
client involvement varied
Beliefs: Negative
aspects of
involvement
￿ One client sited immaturity and another felt that young
people were not qualified
￿ One caregiver felt unable to be involved when
experiencing her own mental distress
Beliefs: Improving
the decision-making
process
￿ Suggestions influenced by experiences
￿ Advocates on inpatient unit
￿ Plan for therapy from the start
￿ Wanted to be ‘taken seriously’
￿ Meaningful information that drew on existing personal
knowledge
￿ Interactive fact sheets
￿ Information, particularly about mental disorders
Barriers to
involvement
￿ System level barriers e.g. lack of time in consultations
￿ Relationship barriers e.g. lack of communication or trust
￿ Personal barriers e.g. age
￿ Service barriers e.g. confidentiality policies
￿ Relationship barriers e.g. exclusion by clinicians and
offspring
￿ Personal barriers e.g. own mental health issues
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involvement, for example because they felt too unwell to
be involved, whereas others were not, as in the above
example.
Caregivers reported actively encouraging their sons and
daughters to be involved in the decision-making process.
They generally saw this as important not only for their
engagement in the service, but also for their development
as individuals in terms of maturation. Caregiver 03 said:
“I feel you know at fifteen and sixteen... they have to
start taking some responsibility for themselves. They
have to do that break away from mum bit. That’s
the whole teenage thing.”
Two caregivers added caveats; one felt that her son
should feel as if he was involved, but ultimately that she
should decide what was best for him, and another felt that
her son should be involved in so far as providing informa-
tion and being informed, but that the clinician should
make the final decision.
Caregiver involvement
Most caregivers had similar experiences of the ways in
which they were involved both in the care of their off-
spring and also in the decision-making processes. Care-
givers reported having essential roles in terms of
practical support such as facilitating service use (e.g.
driving their children to appointments) and managing
medication (e.g. filling prescriptions for medication),
however they reported being quite removed from treat-
ment overall, including from both the decision-making
process itself and also making decisions about treat-
ment. All caregivers had been asked by clinicians for
information about their child, in line with the passive
involvement category defined by Charles and colleagues
[19], but few were consulted fully about treatment deci-
sions. Whether or not this was a concern to the care-
giver differed, and this was influenced both by their
appraisal of their child’s capacity to engage in treatment
and make decisions, and also by their level of trust in
the treating clinician and/or team. For example, when
caregiver 02’ss o nw a sp u to nm e d i c a t i o n ,“Iw a s n ’t
asked for my opinion but that didn’t worry me because
I thought, these people are supposed to know what
they’re doing”. It was also influenced by caregivers’ per-
ceptions of themselves; for example, one caregiver who
was a nurse and researched medications thoroughly felt
that it would be beneficial for her to be involved, whilst
another caregiver who was diagnosed with Bipolar Dis-
order said that at times she wanted to be involved
because of her knowledge based on experience, whereas
at other times she couldn’t be involved because she was
unwell herself. Many caregivers also spoke of the
difficulties they had experienced with age-based policies
at services, such as caregiver 03:
“Because at the age of sixteen they’re sort of
classed... almost like an adult... I find that hard,
because she’sn o ta na d u l t ,s h e ’s not an adult until
she’s eighteen, and until that time I’m responsible
for her. So if I’m responsible for her... I need to have
information on what’s happening within her
treatment.”
Caregivers reported that this lack of knowledge
impacted on their ability to provide the care that they
wanted.
In terms of caregiver involvement from the perspective
of clients, four clients had been living in foster care or
under custody orders from early ages. Any involvement
from parents or other caregivers such as case workers
was very limited, and at times that lack of support made
decision making difficult: client 08 described feeling
alone in the decision-making process because she was
“making (my) own decisions bringing (myself) up”.T h i s
sense of needing to be self-reliant was often spoken
about in relation to clients’ perception of involvement
being a basic right (as discussed below in ‘Importance of
being involved’). Many of the clients who did have care-
giver involvement reported at least one negative experi-
ence. All clients felt that caregivers should be involved to
some degree, however, and there was a general consensus
that caregivers should play a supportive role rather than a
decision-making role.
Clinician involvement
When asked about the involvement of clinicians, some
clients felt that it was important for clinicians to be
involved in the decision-making process, others said that
it depended on the clinician (e.g. one client was happy
for his case manager to be involved, but didn’tw a n th i s
doctor involved), and nobody advocated for a model
where clinicians’ input was excluded. All clients wanted
clinicians’ input to be of a collaborative nature except for
client 03, who said that he wanted the clinician to set the
agenda for treatment. He felt that if it were left up to
him, then he wouldn’t feel confident in his choices and
may miss opportunities for recovery given the time lim-
itations of the service. An example of the desire for a col-
laborative approach was client 05 who wanted her
clinician to provide information to her, but also for her
clinician to consider her past experiences and wishes,
and to follow up and monitor her in order to demon-
strate that they ‘care’. Interviewees were also asked
directly whom they thought should weigh up the poten-
tial risks and benefits of treatment options. All responses
except for two focused on the client and the clinician
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cian had explained the potential risks and benefits or
offering their advice. Clients 01 and 03 also felt that care-
givers should be involved in this ‘weighing up’ process,
however client 03 qualified this by saying that it should
be dependent on the age of the client and also that the
information given to clients should be ‘watered down’ so
as not to deter them from seeking help.
Most caregivers felt a need to be able to trust the experi-
ence and knowledge of the clinicians (as “experts”), whilst
at the same time acknowledging that they themselves were
t h ep e o p l ew h o“know (their) kids, know what (they’re)
like” [caregiver 03]. So although some caregivers were will-
ing to trust clinicians implicitly (even if they had reserva-
tions), others wanted clinicians to act more as providers of
information and for caregivers themselves to have the final
say when making decisions. Caregivers reported mixed
feelings about the quality of care provided by different
clinicians, and this impacted on the level of trust they felt
for each clinician.
Information
The level of information provided to clients varied across
clients, clinicians, services, and also within clients across
time. Generally the information received was described as
lacking or poor. Many clients sought information else-
where, including other clinicians (e.g. pharmacist), the
Internet, and asking friends and family members. One cli-
ent [client 04] even attended a conference on mental
health to better inform himself. Some clients felt reluctant
or unable to ask for more information from their clinician,
particularly if the rapport was compromised. Yet informa-
tion was seen as an important factor in the decision-mak-
ing process, especially in terms of feeling comfortable with
the decision. The type of information desired by clients
overall was summarized well by client 10, who felt that it
was important to know about “alternative stuff” (treatment
options), to have “realistic expectations”,g o o di n f o r m a t i o n
about cognitive therapy and medication, and to be pro-
vided with honest information about potential risks
(mainly side effects). Caregivers reported receiving even
less information, and this compounded their feelings of
exclusion (e.g. lack of awareness of what was going on
during clinical sessions) and confusion (e.g. coming to
terms with the experiences, diagnoses and treatment
options for their child). Some caregivers received informa-
tion from their child who shared items such as fact sheets
with them, and others initiated their own research (usually
on the internet).
What should occur?
Desire for involvement
The majority of clients preferred a collaborative style
approach (whereby both the doctor and client worked
together to make the decision about treatment), although
desire for involvement varied both within and across
clients. Additionally, views about who should be involved
and their roles varied within the different preferences for
involvement. If there was a certain level of trust in clini-
cians and/or caregivers (e.g. good rapport, a feeling of
mutual respect), then some clients were willing for their
own involvement to be less prominent. Issues that clients
reported as having influenced their desired level of invol-
vement were age, severity of symptoms and levels of sup-
port. A distinction was often drawn between being
involved in the decision-making process (e.g. discussing
the options) and making the final decision [25]. For
example, client 02 was happy to be quite passive in the
decision-making process (e.g. not be involved in informa-
tion sharing or discussing the potential risks and benefits
of treatment options), but he wanted to be the one to
make the decision. Client 03, the only participant who
thought that young people should be involved as little as
possible in the decision-making process, also described
an experience where he ceased medication without the
involvement of his clinicians or caregiver in order to
illustrate that the decision was ultimately his.
All caregivers wanted some involvement, although the
degree to which they wanted to be involved varied. One
caregiver said that she would listen to the opinions of her
son and the clinicians, but then she would always make
the final decision. She even went so far as to say that if the
clinician didn’t agree with her that she would take her son
to a different service. She also reported that she often
went in to her general practitioner already having made
her mind up about the treatment decision outcome, and
this included asking for (and subsequently receiving a pre-
scription for) antidepressant medication for her son.
Another caregiver held contrasting views and felt that clin-
icians should always be the ones to make decisions about
treatment and she said that she just had to trust that the
right decision was being made, even if she (or her son)
didn’t agree with the outcome. The remaining three care-
givers wanted to play equal roles in collaboration with
their child and the relevant clinicians.
Importance of being involved
All but one of the clients advocated for significant client
involvement; as mentioned above, client 03 did not think
that young people should be involved in decision making
about treatment for depressive disorders. For others,
there were a variety of reasons given about why it was
important to be involved in the decision-making process.
These included the engagement process, adherence to
treatment, safety, autonomy and empowerment. Client
01 felt that the level of involvement “impacts (my) will-
ingness to seek treatment” both at the time and in the
future, and his experiences of not being involved made it
difficult for him to want to subsequently seek help or
agree with decisions. Interviewees also thought that their
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their adherence to medication. Although he generally
adhered to his medication regime, client 01 felt that if he
was more involved by being provided with more informa-
tion, then “I probably would have been more happier to
take it (antidepressant medication)”. For others who had
been non-adherent in the past, improvements in the
decision-making process meant that they were more will-
ing to take medication.
Feeling empowered and autonomous was important in
and of itself for some clients, and for others this was
also important for safety (e.g. being able to recognize
side effects and knowing what to do about them). Client
10 believed that:
“young people need to feel control and they need to
sort of feel empowered and I think they should be
informed about... the drug and everything like that so
yeah I think they should be pretty involved in making
that decision to go on the medication”.
Without involvement, client 05 felt like “things (are)
out of my power or out of my control”, but when she did
experience a collaborative approach, this opened up a
dialogue between the clinician and herself:
“I know I was really concerned about being safe about
it too... I was able to ask questions without feeling
judged about like is it okay if I take the Mirtazapine
at night after I’ve had a few drinks you know and how
does it work with alcohol and these kind of things
and instead of someone saying no you shouldn’t really
drink when you’re taking it it was more like well if
you drink while you’re taking it it probably doesn’t
have the same beneficial effects so explaining it in
that way without being judging was really helpful”
Interviewees also spoke more specifically about how
they wanted to be involved, and the role of personal char-
acteristics, values and preferences was often spoken
about before interviewees were asked about these topics
directly. Having the final say was seen as a given, a basic
or human right: “because you know they’re (young peo-
ple) human they should be able to make decisions” [client
10]; “doctors throw in suggestions and that but in the end
no one can make me go anywhere really” [client 07]. The
importance of being involved in treatment decision mak-
ing also began before treatment was sought for some cli-
ents. Client 04 had two experiences of seeking help; one
that involved being told by his parent that he was going
to see a clinician whereby he failed to engage, and
another where he was asked if he would like to “do some-
thing” about feeling depressed, after which he agreed to
attend and engaged well.
All but one caregiver felt that their involvement was
important because they knew their son or daughter in a
different way to their clinicians. Also, their care for their
child remained constant, whereas involvement with ser-
vices and clinicians was more infrequent and changed
over time. As caregiver 03 put it: “they see a psychologist
what, once a week, once a fortnight, once a month in
some cases. I’m the one doing the ongoing care.” Care-
g i v e r sa l s ot h o u g h tt h a ti tw a si m p o r t a n tt oi n v o l v et h e
young person as well, although the extent to which they
felt this should be done varied.
Negative aspects of being involved
When asked, only two clients could think of negative
aspects of being involved in the decision-making process.
Client 09 felt that some young people might be too
immature to be involved and client 03 felt that “if you
knew what you were doing you wouldn’tb ei nt h e r a p y ”,
and that for people with a “mental illness”, information
should be kept to a minimum. The only negative aspect
of being involved from the caregivers’ perspectives was
reported by caregiver 02 who felt unable to be involved
when she was experiencing mental distress herself (as
discussed above).
Improving the decision-making process
Suggestions for how to improve the decision-making pro-
cess from clients varied and were influenced by the
experiences that each client had. For example, client 01
had negative experiences at an inpatient unit, so he felt
that there should be advocates placed on the ward in
order to support the decision-making choices of the cli-
ent. One client (03) who had expressed concern about
making the most of therapy sessions said that he would
have liked a more structured plan about therapy from the
beginning, because early on he “didn’tr e a l l yk n o ww h e r e
it was all heading”. He said that without a clear plan it
was “hard to come in every week sometimes when you
don’tk n o ww h a t ’sc o m i n gn e x t ” and now that he was
nearing discharge from the outpatient service he would
like to have a clearer idea about how far he had pro-
gressed in relation to where he “should be” at. For other
clients, “being taken seriously” (05) as a young person
was key to improving the decision-making process. As
one client put it (01): “some services, like, you could be
there as a patient and they would still want you to be
twenty five with a bachelors’ degree before they would
take your opinion on anything”.
T h em a j o r i t yo fc l i e n t sf e l tt h a tm o r ei n f o r m a t i o nw a s
needed in order to improve the decision-making process,
and it was important for them that the information drew
on existing personal knowledge so that it was meaningful.
Client 06 provided an example of a time when she
received information that was in line with her under-
standing of medication, and said that it was beneficial
because the psychiatrist “could have just given me a
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been helpful at all”. Client 09 wanted more information
in the form of fact sheets “but ones that you’ve gotta fill
out and stuff"; that they were interactive was important
to him. Client 05 felt that more information would have
helped her to avoid a lot of the negative experiences she
had when seeking help during her teenage years; when
asked what information she would have liked, she said
that it would be “amazing if I could see on a piece of
paper options for treatment my god that would just be
insane... that would be mind blowing to discuss what I
think would work best with my personality”.T h i s
response was made without prior discussion of shared
decision making or decision support tools. Caregivers
also felt that more information would have improved
their experiences, particularly in relation to information
about mental disorders.
Barriers to involvement
Barriers to involvement in the decision-making process
Clients spoke about barriers to involvement in the deci-
sion-making process in three different contexts: at a sys-
tem level, at a relationship level with clinicians and at a
personal level. In terms of system-level barriers, a lack of
time for questions during consultations was raised for cli-
ents who were treated in general practice and inpatient
units. Barriers at a relationship level included miscom-
munication or a lack of communication with their clini-
cians, and breaches in trust (clients not trusting the
clinician and/or clients not feeling trusted by their clini-
cian) as issues. Perhaps surprisingly, symptoms of depres-
sion were only described by two respondents as being a
barrier to being involved in the decision-making process
(05 and 08), and the only other personal barrier that was
reported was being young, where one client (01) likened
being young to his negative experiences at an inpatient
unit: “I wasn’t involved then [when aged 12-13], like a lot
of the times I didn’t even like consult with people making
the decisions it was a lot like um being an inpatient in my
own life”. For caregivers, the main barriers related to ser-
vice settings and clinicians, although caregivers also
reported instances where the i rc h i l dh a de x c l u d e dt h e m
from the decision-making process. Caregivers spoke
about age ranges not necessarily matching developmental
stages, and how this made it difficult to respect the confi-
dentiality policies of services.
Discussion
The most striking finding from these data is the variabil-
ity in experiences of and desire for involvement in treat-
ment decision making, both within and across clients,
clinicians and services. Yet involvement, at some level, in
the decision-making process was important to all clients
for a broad range of reasons. This complements results
from research into preferences for involvement in adults
with mental disorders [36-38], and it would be of benefit
to further investigate the preferences for involvement
that young people with depressive disorders seen at a lar-
ger range of services have, to further increase our knowl-
edge about the generalisability of this finding. Particularly
given that young people [e.g. [55]] and adults diagnosed
with depression [e.g. [56]] have demonstrated increased
preferences for involvement. Despite showing a strong
desire to be involved in the decision-making process, all
clients wanted at least some involvement from their clini-
cians, which supports a collaborative model rather than
an autonomous model [19]. It also demonstrates that cli-
ent preferences for involvement do not always fit the
three main models of involvement (e.g. paternalistic,
shared and autonomous). Therefore, a more flexible
understanding of involvement that incorporates more
complex combinations of preferences is necessary
[20,25]. The desire for involvement of caregivers varied
across clients. Clients’ accounts of what constituted true
involvement for them focused on factors related to key
aspects of the client-clinician relationship, such as
engagement and adherence, as well as patient centered
g o a l ss u c ha sa u t o n o m ya n de m p o w e r m e n t .T h i ss u p -
ports the notion that conceptualizations of involvement
should acknowledge and consider the views and feelings
of clients (and caregivers) about their relationships with
clinicians [21,57]. In line with recent calls promoting
SDM for mental disorders [14,15], these data support a
focus on involvement in decision-making processes for
young people with depressive disorders.
The provision of information was also variable across
clinicians and services, yet most clients and caregivers
voiced a desire for more information. This is in line with
previous research investigating the experiences and pre-
ferences of adults and adolescents receiving treatment for
depression [46,50]. For clients it was important that this
information accounted for their values and preferences.
Some clients felt unable to ask for information, even
though they felt that they didn’t have sufficient informa-
tion to be involved in the decision-making process or
understand why a treatment was being offered and/or
feel satisfied with the decision-making process. Signifi-
cant barriers were discussed by clients, both in terms of
access to services at all and also in terms of being
involved in the decision-making process once gaining
access to a service.
There are several reasons why informative resources
that promote the inclusion of young people in decision-
making processes are difficult to produce and may not be
available. Reasons may include: a lack of evidence to base
information on and the need to update resources accord-
ing to the latest evidence; challenges with dissemination
(e.g. translating evidence into readily accessible and
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tion (e.g. enlisting the support of organizations and clini-
cians). Information resources need time for ongoing
development and, therefore, ongoing financial commit-
ments from services. While potentially costly, they would
provide a systematic way to ensure the opportunity of
involvement of each client. Given the significant pro-
blems with help seeking in this population [7,8], there is
an onus on service providers to employ tactics that maxi-
mize engagement and adherence to the chosen treatment
option. Past negative treatment experiences have been
highlighted elsewhere [12] as a key factor related to
accepting a diagnosis of a depressive disorder and, there-
fore, impacting on help-seeking behaviour, which was
echoed in the findings of this study. The need to choose
treatments that are preference based and clinically effec-
tive in collaboration with the young person upon initial
engagement in a service is twofold; with the hope that
the treatment will work first time round, and if this is not
achieved, that the young person will be willing to remain
engaged and pursue further treatment options.
Caregivers found barriers in gaining access to services
for their children, but also barriers to being involved in
their care once accepted into services. The issue of the
age of their children and associated confidentiality poli-
cies was the biggest concern reported by caregivers.
Whilst such policies are unlikely to change, the use of
decision support tools may be one way in which to either
involve caregivers in the decision-making process (if so
desired by the client) or communicate to caregivers the
rationale for the decision made so that they can at least
understand what is happening and why.
The experiences of the clients highlighted gaps in the
decision-making process, and clients offered ways in
which to improve such processes. Information that was
interactive and meaningful was a priority for clients, as
was feeling as if they were respected and taken seriously
by their clinicians. This priority, in combination with cli-
ents’ desires to have their personal characteristics, values
and preferences considered, clearly supports the use of
decision support tools and shared decision making.
Given that preference for involvement is likely to change
over time, having tools available to use on a repeated
basis as decisions are revisited seems warranted. Under-
standing treatment options both for themselves and also
to explain to caregivers if appropriate, was important for
clients in order to navigate the complex process of seek-
ing help and engaging with services.
There are several limitations to the current study.
Although we undertook the study in order to obtain a
rich description of experiences and beliefs based on a
purposive sample, the small sample size minimizes the
generalisability of these findings. While the participants
were recruited from only two services, they had all
experienced treatment decision-making at other services
and therefore data were obtained for experiences at gen-
eral practice, enhanced general practice, the public men-
tal health system and private practitioners. We
acknowledge, however, that there are likely to be charac-
teristics unique to this sample that may not be present
in the broader population. Given that a secondary aim
was to look for ways in which decision making could be
improved at each service, we wanted to recruit current
clients of the services. This meant that recruitment was
difficult, as the clinical needs of the young people
needed to be prioritized. Efforts were made, however, to
review the interview data as they were being collected to
ensure that different types of experiences and beliefs
were being addressed. Most young people and caregivers
were interviewed as they were being discharged from
the service, which meant that they could reflect on their
time at the service as well as experiences at services
prior to attending their current service. Another limita-
tion is that participants were asked to recall events that
they had experienced over several years. In line with our
approach, however, we were interested in participants’
accounts of their experiences rather than what actually
happened. We feel that concepts such as involvement
can be very subjective and different parties (e.g. doctor
and patient) may describe an encounter such as treat-
ment decision making in very different ways. How
young people and their caregivers make sense of such
encounters can help us to understand and improve
aspects such as treatment decision making.
Conclusions
This study is the first to consider the experiences and
beliefs of young people and their caregivers about treat-
ment decision making for depressive disorders. Clinical
guidelines advocate for the inclusion of young people in
such decision-making processes and the current study
supports this.
The difficulty that clients reported getting accepted into
services demonstrates that there is an onus on services to
maximize efforts to engage clients once accepted. Given
that clients reported a direct relationship between involve-
ment and outcomes such as engagement, adherence and
satisfaction with services, the importance of at least offer-
ing clients involvement in the decision-making process
was highlighted. This is particularly true for clinicians or
services that either precluded involvement or from which
clients readily disengaged.
The factors that influence desire for involvement will
not always be evident to clinicians and therefore involve-
ment should be negotiated explicitly (rather than assuming
the level of involvement that the client desires and/or can
cope with) and repeatedly (because desire to be involved is
likely to change over time). Caregiver involvement should
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givers should be supported with the necessary information
about mental disorders and treatment options, particularly
when they are responsible for key tasks outside of the clin-
ical sessions (such as filling prescriptions and monitoring
risk levels).
This study fills a gap in the knowledge about the con-
text in which young people diagnosed with depressive
disorders find themselves making treatment decisions,
and provides the basis on which to build a body of work
looking at the needs of such young people. Further
advancement of this area, including the development of
quality decision support tools to facilitate shared deci-
sion making, will open up the possibility of improved
decision-making experiences for young people, which
has the potential to improve key clinical outcomes for
this population.
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